Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Delphax [Member]
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from line of credit	$ 313,692
Net loss	(7,989,380)	(736,040)
Gain on sale of marketable securities	(143,869)
Gain on sale of property and equipment		(5,024)
Change in accounts receivable and inventory reserves	2,348,788	9,528
Depreciation, amortization and impairment	1,989,601	178,617
Change in cash surrender value of life insurance	(18,571)	(20,146)
Warranty reserve.	39,001	(22,440)
Other-than-temporary impairment loss on investments	1,502,239
Accounts receivable	1,117,413	(774,712)
Notes receivable	(406,552)	257,385
Inventories	(5,704,755)	(3,729,103)
Prepaid expenses and other assets	534,759	211,559
Accounts payable	1,864,793	639,787
Accrued expenses	744,233	78,301
Income taxes payable/receivable	(428,132)	(602,588)
Non-current liabilities	(207,494)
Total adjustments	3,231,454	(3,778,836)
Net cash used in operating activities	(4,757,926)	(4,514,876)
Purchases of marketable securities	(924,623)	(1,070,456)
Proceeds from sale of marketable securities	1,215,105
Proceeds from sale of property and equipment		19,163
Capital expenditures	(519,569)	(219,496)
Increase in restricted cash	(3,411)	(3,316)
Net cash used in investing activities	(232,498)	(1,274,105)
Proceeds from line of credit	12,047,913
Payments on line of credit	(8,727,210)	(18,704)
Net cash provided by (used in) financing activities	3,634,395	(18,704)
Effect of foreign currency exchange rates on cash and cash equivalents	(19,450)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(1,375,479)	(5,807,685)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	5,345,455	13,388,767
CASH AND CASH EQUIVALENTS AT END OF PERIOD	3,969,976	7,581,082
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING ACTIVITIES:
Finished goods inventory transferred to equipment leased to customers	321,345
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest	2,319	20,497
Income taxes	$ 56,133	$ 269,701